First-of-its-kind CAR T clinical trial enrolls HER2+ breast cancer patients with brain metastases

October 30, 2018 | City of Hope

City of Hope is now enrolling patients in a phase 1 trial evaluating the safety and efficacy of CAR T cell therapy in patients with HER2+ breast cancer that has metastasized to the brain.

Continue Reading

New hormone and immunotherapy trial for breast cancer patients

October 8, 2018 | City of Hope

This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.

City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial

June 29, 2018 | Letisia Marquez

California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.

Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Jianjun Chen, Ph.D., Takes Aim at Acute Myeloid Leukemia

May 15, 2018 | City of Hope

Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about acute myeloid leukemia (AML), one of the most common and deadly forms of blood cancer.

John Williams, Ph.D.: Building Better Antibodies

April 20, 2018 | City of Hope

City of Hope researchers use novel technology to add new functionalities to already potent proteins.

Farah R. Abdulla, M.D., Joins Lymphoma Research Team

January 25, 2018 | City of Hope

Farah Abdulla, M.D., specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin.

Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma

November 17, 2017 | City of Hope

City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.

Immunologist Bart Roep, Ph.D., Thinks T1D Cure Is in Sight

June 27, 2017 | Samantha Bonar

Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes.

City of Hope Presents Groundbreaking Research at ASCO 2017

June 2, 2017 | Letisia Marquez

City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.